In spite of the global crisis of #AMR, another pharmaceutical company abandons antibacterial drug development. We need alternative models to fund such programs and support for researchers at academic institutions working on anti-bacterials.
In spite of the global crisis of #AMR, another pharmaceutical company abandons antibacterial drug development. We need alternative models to fund such programs and support for researchers at academic institutions working on anti-bacterials.
11
115
232
115K
48